The term PCDHGA7_Pcdhga7 Activators appears to be a designation for a group of compounds that would be designed to interact with a protein encoded by the Pcdhga7 gene. If we assume that PCDHGA7 refers to a type of protocadherin, a family of molecules involved in cell adhesion, then activators targeting this protein would be specialized to bind and increase its activity. The development of such activators would require a comprehensive understanding of the protein's molecular structure, particularly focusing on the domains responsible for its adhesive functions and any regulatory mechanisms it might be involved in. Given the complexity of protein structures, techniques such as X-ray crystallography or cryo-electron microscopy would be employed to reveal the three-dimensional conformation of PCDHGA7, providing insights into potential binding sites for activators. This structural knowledge would be pivotal for the subsequent stages of activator design, informing the creation of molecules that can precisely modulate the function of PCDHGA7.
The journey from theoretical concept to tangible molecules in the case of PCDHGA7_Pcdhga7 Activators would entail a detailed and iterative research process. Computational chemists would utilize the structural data of PCDHGA7 to perform molecular docking and dynamics simulations, identifying candidate compounds that might potentiate the activity of the protein. These candidate activators would then be synthesized and rigorously tested in a variety of biochemical assays to validate their efficacy and specificity in interacting with PCDHGA7. These assays would provide critical feedback on the binding affinity and functional impact of the compounds, allowing for refinement of the activators' structures to enhance their interaction with PCDHGA7. Through such an iterative cycle of design, synthesis, and validation, a collection of PCDHGA7_Pcdhga7 Activators could be developed, which would serve as important probes to investigate the biological role of the PCDHGA7 protein in cellular adhesion processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
This compound is a DNA methyltransferase inhibitor which may lead to demethylation and activation of gene expression, potentially affecting PCDHGA7. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As a histone deacetylase inhibitor, it could relax chromatin structure, enhance gene transcription, and possibly induce PCDHGA7 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
It is another histone deacetylase inhibitor that might upregulate gene expression by altering chromatin structure, potentially including PCDHGA7. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Involved in gene regulation during development, retinoic acid could influence the expression of developmental genes including PCDHGA7. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
As a steroid hormone, it can modulate gene expression through estrogen receptor signaling and might affect PCDHGA7 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
It activates adenylate cyclase, leading to an increase in cAMP which can modulate various signaling pathways and potentially gene expression profiles. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
This compound is a histone deacetylase inhibitor that can induce hyperacetylation of histones, potentially leading to increased expression of PCDHGA7. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
It modulates gene expression through the vitamin D receptor, which could include effects on PCDHGA7 gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Found in green tea, this polyphenol may have epigenetic modulating activity that could affect PCDHGA7 expression. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $30.00 $115.00 $900.00 | 136 | |
Used as a solvent in biological studies, DMSO can sometimes influence gene expression profiles non-specifically, potentially affecting PCDHGA7. |